{
    "title": "To amend the Public Health Service Act with respect to the operation by the National Institutes of Health of an experimental program to stimulate competitive research.",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``National Institutes of Health EPSCoR \nProgram Act of 2001''.\n\nSEC. 2. EPSCOR PROGRAM AT NATIONAL INSTITUTES OF HEALTH.\n\n    Part A of title IV of the Public Health Service Act (42 U.S.C. 281 \net seq.) is amended--\n            (1) in section 402--\n                    (A) by striking subsection (g); and\n                    (B) by redesignating subsections (h) through (l) as \n                subsections (g) through (k), respectively; and\n            (2) by adding at the end the following:\n\n``SEC. 404E. EXPERIMENTAL PROGRAM TO STIMULATE COMPETITIVE RESEARCH.\n\n    ``(a) In General.--\n            ``(1) Enhancing research competitiveness of eligible \n        institutions.--The Director of NIH, acting through the Director \n        of the National Center for Research Resources, shall in \n        accordance with this section establish a program for the \n        purpose of enhancing the competitiveness of eligible \n        institutions in obtaining funds from the national research \n        institutes for conducting biomedical and behavioral research.\n            ``(2) Eligible institutions; epscor states, committees, and \n        fiscal agents.--In this section:\n                    ``(A) Eligible institution.--The term `eligible \n                institution' means a research entity located in an \n                EPSCoR State.\n                    ``(B) Research entity.--The term `research entity' \n                means a non-Federal entity that conducts biomedical or \n                behavioral research, including an individual or \n                organization.\n                    ``(C) Epscor state.--The term `EPSCoR State' means \n                a State for which--\n                            ``(i) the aggregate success rate for \n                        applications submitted to the national research \n                        institutes by research entities in the State \n                        has historically constituted a low success rate \n                        of obtaining funds from such institutes, \n                        relative to such aggregate rate for research \n                        entities in other States; or\n                            ``(ii) the average of the annual aggregate \n                        amount of funds received for the 5 preceding \n                        fiscal years by research entities in such State \n                        pursuant to successful such applications was \n                        not more than 1.08 percent of the total amount \n                        that was received during such years by research \n                        entities in the States under grants, \n                        cooperative agreements, and contracts awarded \n                        by the national research institutes to support \n                        the conduct of biomedical and behavioral \n                        research.\n                    ``(D) NIH epscor committee.--\n                            ``(i) In general.--The term `NIH EPSCoR \n                        committee' means, with respect to an EPSCoR \n                        State, the single committee established for the \n                        State under section 113 of the National Science \n                        Foundation Authorization Act of 1988 (Public \n                        Law 100-570), except as provided in clause \n                        (ii).\n                            ``(ii) Exception.--A committee referred to \n                        in clause (i) is not an NIH EPSCoR committee \n                        for a State for purposes of this section \n                        unless, when such committee carries out \n                        activities pursuant to this section, the \n                        following conditions are met:\n                                    ``(I) The membership of the \n                                committee includes individuals who are \n                                representatives from the principal \n                                nonprofit and for-profit biomedical and \nbehavioral research entities in the State.\n                                    ``(II) The membership of the \n                                committee includes representatives of \n                                the State legislature and the office of \n                                the Governor.\n                                    ``(III) The membership of the \n                                committee shall serve staggered 4 year \n                                terms.\n                    ``(E) Epscor state fiscal agent.--The term `EPSCoR \n                State fiscal agent' means a fiscal intermediary that \n                has been approved by an NIH EPSCoR committee for a \n                State, and that acts on behalf of such committee by \n                submitting applications to the Federal Government for \n                awards of grants, cooperative agreements, and \n                contracts, and by disbursing amounts from such awards.\n    ``(b) Technical Assistance; Research Plans.--The Director of NIH \nmay under subsection (a) enhance the competitiveness of eligible \ninstitutions through (directly or by grant or contract)--\n            ``(1) providing technical assistance to such institutions, \n        including technical assistance in the preparation of \n        applications for obtaining funds from the national research \n        institutes;\n            ``(2) assisting the institutions in developing a plan for \n        biomedical or behavioral research proposals; and\n            ``(3) assisting the institutions in implementing such plan.\n    ``(c) Formula Grants for Increasing Institutional Capacity.--\n            ``(1) In general.--In the case of each EPSCoR State fiscal \n        agent that in accordance with paragraph (3) submits to the \n        Director of NIH an application for a fiscal year, the Director \n        shall under subsection (a) make an award of a grant or \n        cooperative agreement for the fiscal year to such agent for \n        disbursement to eligible institutions in such State to carry \n        out the purposes described in paragraph (2) (subject to amounts \n        being appropriated under subsection (e) for the fiscal year). \n        The grant shall consist of the allotment determined for the \n        State under paragraph (4).\n            ``(2) Authorized expenditures.--The purposes referred to in \n        paragraph (1) with respect to an EPSCoR State are as follows:\n                    ``(A) Improving the capacity of eligible \n                institutions in the State to conduct biomedical and \n                behavioral research through providing for faculty-\n                related enhancement and development programs (or other \n                programs regarding professional staff); student \n                programs; training programs; obtaining equipment, \n                including instrumentation; obtaining facilities, \n                including the construction or renovation of facilities; \n                establishing collaborative professional relationships \n                with other public or private research entities; and \n                other programs or activities determined by the Director \n                of NIH to be appropriate.\n                    ``(B) Carrying out projects that will have \n                significant short-term impact with respect to improving \n                the capacity of the institutions to conduct biomedical \n                and behavioral research.\n            ``(3) Application for grant; certain requirements.--An \n        application under paragraph (1) for an award for a fiscal year \n        regarding an EPSCoR State is in accordance with this paragraph \n        if the following conditions are met:\n                    ``(A) The application identifies the specific needs \n                of eligible institutions in the EPSCoR State with \n                respect to the purposes described in subparagraphs (A) \n                and (B) of paragraph (2), including identifying the \n                categories of research that are to receive priority.\n                    ``(B) The application contains a plan for obtaining \n                public or private funds (other than from awards under \n                paragraph (1)) to continue in effect the improvements \n                to be made with respect to such institutions pursuant \n                to the award.\n                    ``(C) The EPSCoR State fiscal agent agrees that, \n                not later than 60 days after the end of the fiscal \n                year, the agent will submit to the Director of NIH a \n                report describing the purposes for which the award was \n                obligated or expended.\n                    ``(D) The application meets such additional \n                requirements as the Director of NIH may establish, \n                except that the Director may not require that non-\n                Federal contributions be provided as a condition of \n                receiving the award.\n                    ``(E) The NIH EPSCoR committee for the State has \n                approved the application as adequately meeting the \n                conditions described in subparagraphs (A) through (D).\n            ``(4) Amount of award.--For purposes of paragraph (1), an \n        allotment for an EPSCoR State for a fiscal year is determined \n        in accordance with this paragraph if the allotment is the \n        quotient of--\n                    ``(A) the amount appropriated under subsection (e) \n                and available for awards under paragraph (1); divided \n                by\n                    ``(B) the number of EPSCoR States for which \n                applications for awards under paragraph (1) for the \n                fiscal year are submitted in accordance with paragraph \n                (3).\n    ``(d) EPSCoR Cofunding Program.--\n            ``(1) In general.--The Director of NIH shall under \n        subsection (a) make awards of grants to eligible institutions \n        for the purpose of carrying out projects of research within \n        categories identified under subsection (c)(3)(A) as priorities \n        for the eligible institutions involved.\n            ``(2) Cofunding.--\n                    ``(A) In general.--The Director of NIH may make an \n                award under paragraph (1) only if, in addition to such \n                award, the project involved will receive funding from \n                one or more other programs that are carried out by any \n                of the national research institutes (which other  \nprograms are in this subsection referred to as `Coprograms').\n                    ``(B) Allocation between programs.--Of the total \n                amount made available for a project of an eligible \n                institution pursuant to an award under paragraph (1) \n                and awards under the Coprograms involved, not more than \n                50 percent may be provided in the award under paragraph \n                (1).\n            ``(3) Priorities.--In making awards under paragraph (1), \n        the Director of NIH shall give priority to the following \n        projects:\n                    ``(A) Projects whose principal researchers will be \n                individuals who have not previously served as principal \n                researchers of projects supported by any of the \n                national research institutes.\n                    ``(B) With respect to the process for peer review \n                of applications for awards, projects whose applications \n                under Coprograms were approved in such process but \n                whose rankings precluded the provision of awards.\n                    ``(C) Projects that involve multiple areas of \n                research, each of which areas has, at the eligible \n                institution involved, received funding under this \n                section.\n            ``(4) Certain requirements.--An award under paragraph (1) \n        may be made only if the application for the award meets the \n        following requirements:\n                    ``(A) The application identifies the specific \n                activities to be carried out with respect to the \n                purpose described in paragraph (1).\n                    ``(B) The application meets such additional \n                requirements as the Director of NIH may establish.\n                    ``(C) The NIH EPSCoR committee for the State has \n                approved the application as meeting the requirements \n                under this paragraph, and as being consistent with the \n                strategy adopted by the State with respect to the \n                purpose described in subsection (a)(1).\n    ``(e) Funding.--\n            ``(1) Authorization of appropriations.--For the purpose of \n        carrying out this section, there is authorized to be \n        appropriated $200,000,000 for fiscal year 2002, and such sums \n        as may be necessary for each of the fiscal years 2003 through \n        2006.\n            ``(2) Allocation regarding technical assistance and \n        research plans.--Of the amounts appropriated under paragraph \n        (1) for a fiscal year, the Director of NIH shall reserve not to \n        exceed 10 percent for carrying out subsection (b).\n            ``(3) Allocation regarding formula grants for increasing \n        institutional capacity; allocation regarding cofunding \n        program.--Of the amounts appropriated under paragraph (1) for a \n        fiscal year and available after compliance with paragraph (2), \n        the Director of NIH shall reserve--\n                    ``(A) with respect to fiscal year 2002--\n                            ``(i) 80 percent of such amounts for awards \n                        under subsection (c); and\n                            ``(ii) 20 percent of such amounts for \n                        awards under subsection (d)(1);\n                    ``(B) with respect to fiscal year 2003--\n                            ``(i) 70 percent of such amounts for awards \n                        under subsection (c); and\n                            ``(ii) 30 percent of such amounts for \n                        awards under subsection (d)(1);\n                    ``(C) with respect to fiscal year 2004--\n                            ``(i) 60 percent of such amounts for awards \n                        under subsection (c); and\n                            ``(ii) 40 percent of such amounts for \n                        awards under subsection (d)(1); and\n                    ``(D) with respect to each of fiscal years 2005 and \n                2006--\n                            ``(i) 50 percent of such amounts for awards \n                        under subsection (c); and\n                            ``(ii) 50 percent of such amounts for \n                        awards under subsection (d)(1).\n            ``(4) Additional funding for cofunding program.--In \n        addition to amounts reserved under paragraph (3) for making \n        awards under subsections (c) and (d)(1), the Director of NIH \n        shall reserve for making such awards all savings in the \n        indirect costs of projects of research supported by the \n        national research institutes that are achieved as a result of \n        carrying out projects in EPSCoR States rather than in other \n        States. Such savings shall be calculated based on the previous \n        5 year average of the actual amounts paid to each State in \n        indirect costs. Such additional funding from indirect cost \n        savings shall be allocated in a manner consistent with \n        paragraph (3).\n    ``(f) Reports.--\n            ``(1) To the state.--The NIH EPSCoR committee of a State \n        shall annually submit to the State a report on the activities \n        carried out under this section in the State.\n            ``(2) To nih.--The State shall forward a copy of each \n        report received under paragraph (1) to the Director of NIH.''."
}